SCHEMBL6186290

SCHEMBL6186290

O=C[C@@H](NC(=O)OCc1ccccc1)c1ccc(O)cc1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KLK1 P06870 1/20 0.57
CYP3A4 P08684 7/20 0.52
ALDH1A1 P00352 5/20 0.52
MIF P14174 1/20 0.51
TSHR P16473 3/20 0.51
MAPT P10636 1/20 0.51
CTRB1 P17538 2/20 0.50
LMNA P02545 2/20 0.48
MAPK1 P28482 1/20 0.47
CTSL P07711 1/20 0.47
CTSS P25774 1/20 0.47
CYP1A2 P05177 1/20 0.47
ATM Q13315 1/20 0.47
TP53 P04637 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15330574 1.00 KLK1 (0.57) KLK1CYP3A4ALDH1A1MIFTSHR
SCHEMBL8293263 0.93 CTRB1 (0.54) CYP3A4ALDH1A1TSHRMAPTCTRB1
SCHEMBL29951738 0.82 CTRB1 (0.49) KLK1CYP3A4ALDH1A1TSHRMAPT
SCHEMBL22811058 0.81 LMNA (0.51) CYP3A4ALDH1A1TSHRMAPTLMNA
SCHEMBL14067230 0.80 CYP3A4 (0.54) CYP3A4ALDH1A1TSHRMAPTLMNA
SCHEMBL13721922 0.80 ATM (0.63) KLK1CYP3A4TSHRCTRB1LMNA
SCHEMBL5742261 0.80 ATM (0.67) KLK1CYP3A4ALDH1A1MIFMAPT
SCHEMBL13721804 0.80 ATM (0.63) KLK1CYP3A4TSHRCTRB1LMNA
SCHEMBL5742255 0.80 ATM (0.67) KLK1CYP3A4ALDH1A1MIFMAPT
SCHEMBL17765000 0.80 ATM (0.67) KLK1CYP3A4ALDH1A1MIFMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521742-A1 DIPHENYLAZETIDINONE DERIVATIVES FOR TREATING DISORDERS OF THE LIPID METABOLISM AstraZeneca AB (SE) 2005-04-13 EP disclosed
WO-2004005247-A1 DIPHENYLAZETIDINONE DERIVATIVES FOR TREATING DISORDERS OF THE LIPID METABOLISM ASTRAZENECA AB (SE) 2004-01-15 WO disclosed